Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Sponsor
Abbott (Industry)
Overall Status
Completed
CT.gov ID
NCT00056654
Collaborator
(none)
164
55
1
16
3
0.2

Study Details

Study Description

Brief Summary

The primary purpose of the study is to determine if a new sustained-release 45 mg (depot) formulation of leuprolide acetate will reduce serum testosterone levels to and maintain them at medically castrate levels in subjects with prostatic adenocarcinoma.

Condition or Disease Intervention/Treatment Phase
  • Drug: Leuprolide acetate
N/A

Detailed Description

The primary purpose of the study is to determine if a new sustained-release 45 mg (depot) formulation of leuprolide acetate administered once every 26 weeks for 1 year, will lower testosterone levels to and maintain them at medically castrate levels in subjects with prostatic adenocarcinoma. This study will also evaluate the pharmacokinetic profile of the 45 mg formulation and assess the safety of this formulation.

Study Design

Study Type:
Interventional
Actual Enrollment :
164 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pharmacokinetic, Safety and Efficacy Study of a Six-Month Depot Formulation of Leuprolide in Subjects With Prostatic Carcinoma
Study Start Date :
Mar 1, 2003
Actual Primary Completion Date :
Jul 1, 2004
Actual Study Completion Date :
Jul 1, 2004

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Drug: Leuprolide acetate
45 mg Intramuscular injection 6 month depot formulation

Outcome Measures

Primary Outcome Measures

  1. Suppression of serum testosterone (<=50 ng/dL) and maintenance of serum testosterone suppression once suppression is achieved for individual subjects. [Day 32 through Week 52]

Secondary Outcome Measures

  1. Change from baseline in Eastern Cooperative Oncology Group (ECOG) performance status. [Weeks 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48, 52 and Final Visit]

  2. Change from baseline in symptom severity (bone pain, pain on urination, urination difficulty). [Weeks 1, 4, 8, 12, 16, 20, 24, 26, 27, 28, 30, 32, 36, 40, 44, 48, 52 and Final Visit]

  3. Change from baseline in prostate specific antigen (PSA). [Weeks 1, 12, 26, 27, 30, 40, 52 and Final Visit]

  4. Change from baseline in prostatic acid phosphatase (PAP). [Weeks 1, 12, 26, 40, 52 and Final Visit]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Histological diagnosis of prostate cancer

  • Need for androgen deprivation treatment for 1 year

  • Serum testosterone level ≥ 150 ng/dL

  • Life expectancy of at least 18 months

  • ECOG Performance status grades 0,1 or 2

Exclusion Criteria:
  • Hypersensitivity to leuprolide acetate or polylactic acid

  • History of bilateral orchiectomy, adrenalectomy, or hypophysectomy

  • History of hypogonadism

Contacts and Locations

Locations

Site City State Country Postal Code
1 Urology Centers of Alabama Homewood Alabama United States 35209
2 Medical Affiliated Research Center Huntsville Alabama United States 35801
3 Alaska Clinical Research Center, LLC Anchorage Alaska United States 99508
4 Arkansas Urology Little Rock Arkansas United States 72211
5 Pacific Clinical Center Encino California United States 91316
6 Los Angeles Clinical Research Center Encino California United States 91416
7 Urology Associates of Central California Fresno California United States 93720
8 Center for Urologic Research La Mesa California United States 91942
9 South Orange County Medical Research Center Laguna Woods California United States 92653
10 San Diego Uro-Research San Diego California United States 92101
11 Western Clinical Research Torrance California United States 90505
12 Urology Research Options Aurora Colorado United States 80012
13 Connecticut Clinical Research Center Waterbury Connecticut United States 06708
14 South Florida Medical Research Aventura Florida United States 33180
15 Atlantic Urological Associates Daytona Beach Florida United States 32114
16 UroSearch Inverness Florida United States 34452
17 Advanced Research Institute New Port Richey Florida United States 34652
18 Atlantic Urological Associates New Smyrna Beach Florida United States 32168
19 UroSearch Ocala Florida United States 34470
20 Florida Foundation for Healthcare Research Ocala Florida United States 34474
21 Atlantic Urological Associates Orange City Florida United States 32763
22 Atlantic Urological Associates St. Augustine Florida United States 32086
23 Emory University Atlanta Georgia United States 30322
24 Georgia Urology, PA Atlanta Georgia United States 30342
25 West Side Veteran Administration Medical Center Chicago Illinois United States 60602
26 Kankakee Urological Associates Kankakee Illinois United States 60901
27 Specialty Care Research Peoria Illinois United States 61614
28 Welborn Clinic East Evansville Indiana United States 47713
29 Northeast Indiana Research Fort Wayne Indiana United States 46825
30 Urology of Indiana, LLC Indianapolis Indiana United States 46202
31 Urological Associates, PC Davenport Iowa United States 52807
32 206 Research Associates Greenbelt Maryland United States 20770
33 Lawrenceville Urology St Joseph Michigan United States 49085
34 Kansas City Urology Care Kansas City Missouri United States 64111
35 Saint Louis Urological Surgeons, Inc St Louis Missouri United States 63136
36 Sheldon J. Freedman, MD, LTD Las Vegas Nevada United States 89109
37 Nevada Urology Associates Reno Nevada United States 89511
38 Urological Surgical Associates Edison New Jersey United States 08837
39 Lawrenceville Urology Lawrenceville New Jersey United States 08648
40 Associated Urologic Specialists, PA Marlton New Jersey United States 08053
41 Suffolk Urology Associates Bay Shore New York United States 11706
42 Urological Surgeons of Long Island Garden City New York United States 11530
43 Hudson Valley Urology Poughkeepsie New York United States 12601
44 Center for Urologic Research of Western New York Williamsville New York United States 14221
45 Northeast Urology Research Concord North Carolina United States 28025
46 The Urology Group Cincinnati Ohio United States 45212
47 University Urological Research Institute Providence Rhode Island United States 02906
48 Grand Strand Urology Myrtle Beach South Carolina United States 29572
49 Vanderbilt Medical Center Dept of Urologic Surgery Nashville Tennessee United States 37232
50 Urology Specialists & Associates Dallas Texas United States 75231
51 Urology Associates of North Texas Fort Worth Texas United States 76104
52 Urology San Antonio Research San Antonio Texas United States 78229
53 Salt Lake Research Salt Lake City Utah United States 84124
54 Devine-Tidewater Urology Virginia Beach Virginia United States 23454
55 Madigan Army Medical Center Tacoma Washington United States 98431

Sponsors and Collaborators

  • Abbott

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00056654
Other Study ID Numbers:
  • C02-008
First Posted:
Mar 21, 2003
Last Update Posted:
Sep 17, 2008
Last Verified:
Sep 1, 2008

Study Results

No Results Posted as of Sep 17, 2008